Metropolitan Life Insurance Company (MetLife)’s Itron ITRI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,393	Closed	-$221K	–	1069
2024 Q1	$221K	Sell	2,393 -229	-9%	-$18.4K	0.01%	676
2023 Q4	$198K	Hold	2,622	–	–	0.01%	732
2023 Q3	$159K	Buy	2,622 +133	+5%	+$9.13K	0.01%	782
2023 Q2	$179K	Buy	2,489 +49	+2%	+$3.1K	0.01%	726
2023 Q1	$135K	Sell	2,440 -348	-12%	-$19.2K	0.01%	847
2022 Q4	$141K	Buy	2,788 +97	+4%	+$4.79K	0.01%	876
2022 Q3	$113K	Hold	2,691	–	–	0.01%	945
2022 Q2	$133K	Hold	2,691	–	–	0.01%	903
2022 Q1	$142K	Sell	2,691 -9,196	-77%	-$514K	0.01%	984
2021 Q4	$814K	Hold	11,887	–	–	0.01%	1114
2021 Q3	$899K	Sell	11,887 -689	-5%	-$59K	0.01%	1045
2021 Q2	$1.26M	Buy	12,576 +789	+7%	+$73.2K	0.02%	839
2021 Q1	$1.04M	Buy	11,787 +547	+5%	+$54.1K	0.02%	906
2020 Q4	$1.08M	Hold	11,240	–	–	0.02%	825
2020 Q3	$683K	Sell	11,240 -988	-8%	-$62.8K	0.01%	987
2020 Q2	$810K	Buy	12,228 +1,991	+19%	+$127K	0.01%	866
2020 Q1	$572K	Sell	10,237 -546	-5%	-$41.5K	0.01%	973
2019 Q4	$905K	Sell	10,783 -176	-2%	-$13.9K	0.01%	952
2019 Q3	$811K	Buy	10,959 +9	+0.1%	+$605	0.01%	987
2019 Q2	$685K	Hold	10,950	–	–	0.01%	1111
2019 Q1	$511K	Hold	10,950	–	–	0.01%	1281
2018 Q4	$518K	Hold	10,950	–	–	0.01%	1174
2018 Q3	$703K	Hold	10,950	–	–	0.01%	1136
2018 Q2	$658K	Buy	10,950 +571	+6%	+$36.2K	0.01%	1132
2018 Q1	$743K	Sell	10,379 -622	-6%	-$44.5K	0.01%	1043
2017 Q4	$750K	Sell	11,001 -12,310	-53%	-$880K	0.01%	1039
2017 Q3	$1.8M	Hold	23,311	–	–	0.01%	969
2017 Q2	$1.58M	Hold	23,311	–	–	0.01%	1035
2017 Q1	$1.42M	Hold	23,311	–	–	0.01%	1079
2016 Q4	$1.47M	Sell	23,311 -455	-2%	-$27.4K	0.01%	1093
2016 Q3	$1.32M	Sell	23,766 -3,120	-12%	-$150K	0.01%	1136
2016 Q2	$1.16M	Hold	26,886	–	–	0.01%	1180
2016 Q1	$1.12M	Hold	26,886	–	–	0.01%	1120
2015 Q4	$973K	Buy	26,886 +1,279	+5%	+$45.2K	0.01%	1209
2015 Q3	$817K	Sell	25,607 -920	-3%	-$28.7K	0.01%	1301
2015 Q2	$914K	Buy	+26,527	New	+$963K	0.01%	1351
2015 Q1	–	Sell	-63,008	Closed	-$2.67M	–	2320
2014 Q4	$2.67M	Sell	63,008 -141	-0.2%	-$5.63K	0.02%	849
2014 Q3	$2.48M	Buy	63,149 +54	+0.1%	+$2.16K	0.02%	853
2014 Q2	$2.56M	Buy	63,095 +189	+0.3%	+$7.19K	0.02%	891
2014 Q1	$2.24M	Buy	62,906 +631	+1%	+$23.9K	0.02%	931
2013 Q4	$2.58M	Buy	62,275 +158	+0.3%	+$6.71K	0.02%	840
2013 Q3	$2.66M	Buy	62,117 +65	+0.1%	+$2.66K	0.02%	783
2013 Q2	$2.63M	Buy	+62,052	New	+$2.65M	0.02%	740

Other funds holding ITRI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ITRI Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Itron (ITRI) in Q2 2024, closing a stake of 2,393 shares — an estimated $221K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ITRI in Q2 2013 and held it in 43 quarters. The position peaked at $2.67M in Q4 2014. 409 funds tracked by Wall St. Rank hold ITRI as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Itron position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 2,393 Itron shares in Q2 2024, an estimated $221K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Itron in Q2 2013 and held it in 43 quarters.
Metropolitan Life Insurance Company (MetLife)'s Itron position peaked at $2.67M in Q4 2014.
409 funds tracked by Wall St. Rank held Itron as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.